Sepsis: Preventing organ failure in sepsis — the search continues
Nature Reviews Nephrology 13, 5 (2017).
doi:10.1038/nrneph.2016.171
Authors: Thomas J. Graetz & Richard S. Hotchkiss
In a recent trial, levosimendan therapy failed to ameliorate sepsis-induced organ dysfunction or improve the survival of patients with septic shock. The failure of levosimendan and many other potential therapies for sepsis, together with the findings of histopathologic studies, raise questions regarding the pathophysiologic basis of the disorder.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Thomas J. Graetz Richard S. Hotchkiss Tags: News and Views Source Type: research